• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助化疗期间及术后乳腺癌患者的天然免疫

Natural immunity in breast cancer patients during neoadjuvant chemotherapy and after surgery.

作者信息

Beitsch P, Lotzová E, Hortobagyi G, Pollock R

机构信息

University of Texas, M.D. Anderson Cancer Center, Houston 77030.

出版信息

Surg Oncol. 1994 Aug;3(4):211-9. doi: 10.1016/0960-7404(94)90036-1.

DOI:10.1016/0960-7404(94)90036-1
PMID:7834112
Abstract

Breast cancer is the most common cancer in women. Surgery, and more recently neoadjuvant chemotherapy, are being utilized as the initial treatment for breast cancer; however little is known about their effects on the natural immune system. The natural immune system (natural killer [NK] cells) is thought to be important in immune surveillance, including protection from metastasis during the intravascular tumour seeding that occurs during surgery. To investigate the effects of surgery on the natural immune system, we studied the pre-operative and post-operative peripheral blood lymphocytes (PBL) of 10 patients with stage I or II breast cancer: there was a 71.6 +/- 25.3% post-operative reduction in NK cell function (P < 0.005, Student's paired t-test). To investigate the effects of neoadjuvant chemotherapy and surgery, we examined PBL from five patients with stage III breast cancer: NK cell function dropped 95.7 +/- 1.9% after neoadjuvant chemotherapy, and there was a further 51.0 +/- 23.4% decrease after surgery (P < 0.05, Student's paired t-test). Neither group of patients had decreased numbers of NK cells, changes in the percentage of T helper or suppressor cells, or alterations in the production of cytotoxic factor by NK cells. These findings suggest that the impairment in NK cell function reflects a defect in the ability of NK cells to recognize and/or bind to tumour target cells. We conclude that the initial treatment of breast cancer patients, whether it involves surgery alone or with neoadjuvant chemotherapy, profoundly impairs their natural immune system and could increase the risk of metastasis. Further studies are needed to delineate the mechanism of this derangement in natural immunity and possibly alter its course.

摘要

乳腺癌是女性中最常见的癌症。手术以及最近的新辅助化疗正被用作乳腺癌的初始治疗方法;然而,关于它们对天然免疫系统的影响却知之甚少。天然免疫系统(自然杀伤[NK]细胞)被认为在免疫监视中很重要,包括在手术期间发生的血管内肿瘤播种过程中防止转移。为了研究手术对天然免疫系统的影响,我们研究了10例I期或II期乳腺癌患者术前和术后的外周血淋巴细胞(PBL):术后NK细胞功能下降了71.6±25.3%(P<0.005,学生配对t检验)。为了研究新辅助化疗和手术的影响,我们检查了5例III期乳腺癌患者的PBL:新辅助化疗后NK细胞功能下降了95.7±1.9%,手术后进一步下降了51.0±23.4%(P<0.05,学生配对t检验)。两组患者的NK细胞数量均未减少,辅助性T细胞或抑制性T细胞百分比无变化,NK细胞产生细胞毒性因子的能力也无改变。这些发现表明,NK细胞功能的损害反映了NK细胞识别和/或结合肿瘤靶细胞能力的缺陷。我们得出结论,乳腺癌患者的初始治疗,无论是单独手术还是联合新辅助化疗,都会严重损害其天然免疫系统,并可能增加转移风险。需要进一步研究来阐明这种天然免疫紊乱的机制,并可能改变其进程。

相似文献

1
Natural immunity in breast cancer patients during neoadjuvant chemotherapy and after surgery.新辅助化疗期间及术后乳腺癌患者的天然免疫
Surg Oncol. 1994 Aug;3(4):211-9. doi: 10.1016/0960-7404(94)90036-1.
2
Association of decreased NK cell activity and IFNγ expression with pSTAT dysregulation in breast cancer patients.乳腺癌患者自然杀伤细胞活性降低及干扰素γ表达与磷酸化信号转导和转录激活因子失调的关联。
J BUON. 2011 Apr-Jun;16(2):219-26.
3
Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy.接受新辅助化疗的晚期乳腺癌患者的淋巴细胞亚群
Tumori. 2000 Sep-Oct;86(5):403-7. doi: 10.1177/030089160008600507.
4
Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.自然杀伤细胞活性增强以及抗肿瘤CD8(+) T细胞反应得以保留,有助于HER2阳性乳腺癌患者在接受新辅助化疗后诱导出病理完全缓解。
J Transl Med. 2015 Jun 27;13:204. doi: 10.1186/s12967-015-0567-0.
5
Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.新辅助化疗和手术之后,对临床II期和III期联合乳腺癌单独进行局部放疗。
Radiat Oncol. 2016 Jul 26;11:93. doi: 10.1186/s13014-016-0670-2.
6
Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery.局部晚期乳腺癌(LLABC)女性患者血液和肿瘤中的自然杀伤(NK)细胞特征及其对新辅助化疗(NAC)后肿瘤病理完全缓解(PCR)的贡献:NAC和手术对血液特征的差异恢复作用
J Transl Med. 2015 Jun 4;13:180. doi: 10.1186/s12967-015-0535-8.
7
NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy.乳腺癌患者的自然杀伤细胞和T细胞功能:手术及辅助放化疗的影响
Br J Cancer. 2007 Jul 2;97(1):105-11. doi: 10.1038/sj.bjc.6603840. Epub 2007 Jun 5.
8
The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.化疗和内分泌干预对人乳腺癌自然杀伤细胞活性的影响
Cancer. 1991 Aug 1;68(3):482-8. doi: 10.1002/1097-0142(19910801)68:3<482::aid-cncr2820680306>3.0.co;2-9.
9
A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients.术前化疗诱导乳腺癌患者外周自然杀伤细胞活性的潜在作用。
Cancer Immunol Immunother. 2019 Apr;68(4):577-585. doi: 10.1007/s00262-019-02305-z. Epub 2019 Jan 23.
10
[The effect of sera of breast cancer patients on NK cell activity].[乳腺癌患者血清对自然杀伤细胞活性的影响]
Srp Arh Celok Lek. 1995 Sep-Oct;123(9-10):227-31.

引用本文的文献

1
Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches.探究乳腺癌的肿瘤免疫原性:解析肿瘤免疫应答以增强治疗方法。
Front Immunol. 2024 Oct 23;15:1399754. doi: 10.3389/fimmu.2024.1399754. eCollection 2024.
2
Case Report: Chemotherapy and Radiotherapy Combined With DC-CIK for Pulmonary and Mediastinal Metastases From Nasopharyngeal Carcinoma.病例报告:化疗、放疗联合DC-CIK治疗鼻咽癌肺及纵隔转移
Front Oncol. 2022 Feb 17;12:778643. doi: 10.3389/fonc.2022.778643. eCollection 2022.
3
Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice.
化疗在乳腺癌中的免疫刺激作用:从免疫原性调节机制到临床实践。
Front Immunol. 2022 Jan 5;12:819405. doi: 10.3389/fimmu.2021.819405. eCollection 2021.
4
Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study.运动对(新)辅助化疗期间自然杀伤细胞活性的影响:一项随机试验研究。
Physiol Rep. 2021 Jun;9(11):e14919. doi: 10.14814/phy2.14919.
5
Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response.自然杀伤细胞与抗癌疗法:对免疫功能和治疗反应的相互影响
Cancers (Basel). 2021 Feb 9;13(4):711. doi: 10.3390/cancers13040711.
6
Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment.外周血嗜酸性粒细胞计数在接受新辅助治疗的三阴性和激素受体阴性/人表皮生长因子受体2阳性乳腺癌患者中的预测和预后作用
Oncotarget. 2018 Sep 14;9(72):33719-33733. doi: 10.18632/oncotarget.26120.
7
Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery.局部晚期乳腺癌(LLABC)女性患者血液和肿瘤中的自然杀伤(NK)细胞特征及其对新辅助化疗(NAC)后肿瘤病理完全缓解(PCR)的贡献:NAC和手术对血液特征的差异恢复作用
J Transl Med. 2015 Jun 4;13:180. doi: 10.1186/s12967-015-0535-8.
8
Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response.新辅助化疗期间乳腺肿瘤的系列表达分析揭示了与复发和反应相关的细胞周期和免疫途径的变化。
Breast Cancer Res. 2015 May 29;17(1):73. doi: 10.1186/s13058-015-0582-3.
9
Immunological effects of taxol and adryamicin in breast cancer patients.紫杉醇和阿霉素在乳腺癌患者中的免疫效应。
Cancer Immunol Immunother. 2012 Apr;61(4):481-8. doi: 10.1007/s00262-011-1117-0. Epub 2011 Sep 30.
10
Significant impairment in immune recovery after cancer treatment.癌症治疗后免疫恢复存在显著损害。
Nurs Res. 2009 Mar-Apr;58(2):105-14. doi: 10.1097/NNR.0b013e31818fcecd.